Business Standard

Bharat Immunological & Biological Corporation reports standalone net loss of Rs 9.36 crore in the September 2021 quarter

Image

Capital Market

Sales decline 2.60% to Rs 24.70 crore

Net Loss of Bharat Immunological & Biological Corporation reported to Rs 9.36 crore in the quarter ended September 2021 as against net loss of Rs 3.87 crore during the previous quarter ended September 2020. Sales declined 2.60% to Rs 24.70 crore in the quarter ended September 2021 as against Rs 25.36 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales24.7025.36 -3 OPM %-14.13-17.74 -PBDT-4.50-5.53 19 PBT-4.56-5.59 18 NP-9.36-3.87 -142

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 30 2021 | 9:30 AM IST

Explore News